LifeVantage stock holds steady after Q4 miss and guidance gap

LifeVantage Corporation (US53223L1017) stock closed at USD 6.35 on September 18, 2026, after rising 2.42 percent from the prior session. The latest quarter brought USD 42.38 million in revenue and USD 0.11 in earnings per share, both from the company's fourth fiscal quarter of 2026.

Q4 numbers set the tone

According to MarketBeat, LifeVantage's fourth fiscal quarter 2026 EPS of USD 0.11 missed the consensus estimate of USD 0.12 by USD 0.01, while revenue of USD 42.38 million came in below the USD 44 million estimate. The same source shows trailing-twelve-month EPS of USD 0.40 and net margin of 2.78 percent.

That gap matters because the stock is still priced on a modest valuation profile rather than a growth premium. MarketBeat lists a trailing P/E ratio of 15.88 and a market capitalization of USD 79.57 million as of September 18, 2026.

Analysts stay cautious

According to MarketBeat, LifeVantage carries a consensus rating of Hold and an average price target of USD 5.50, based on two analyst ratings. The same overview shows a high target of USD 6.00 and a low target of USD 5.00, which places the latest close above the average target.

For investors, that combination leaves the next earnings step as the main test. MarketBeat's calendar currently points to an estimated earnings date of November 3, 2026, and the stock's 52-week range runs from USD 3.90 to USD 11.71.

Stock near the range floor

LifeVantage stock traded at USD 6.35 on Nasdaq on September 18, 2026, with after-hours trading at USD 6.36 and volume of 49,743 shares. The market value stood at USD 79.549 million, leaving the shares closer to the 52-week low of USD 3.90 than to the high of USD 11.71.

More news and analyses on LifeVantage stock